Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Russia approves its third Covid-19 vaccine

Chike Olisah by Chike Olisah
February 20, 2021
in Coronavirus
COVID-19 vaccine from Russia
Share on FacebookShare on TwitterShare on Linkedin

Russia has announced that it has approved its third vaccine against the coronavirus disease for domestic use.

Moscow was the first country to register a vaccine against Covid-19, Sputnik V, in August 2020, ahead of trials.

According to a report from Reuters, this was disclosed by the Russian Prime Minister, Mikhail Mishustin, while speaking on State TV, on Saturday, although large-scale clinical trials of the vaccine, labelled CoviVac and produced by the Chumakov Centre, is yet to commence.

RelatedPosts

World Bank says COVID-19 sparked surge in financial inclusion globally

US Vice President, Kamala Harris tests positive for COVID-19

Mishustin said, “Today, Russia is the only country to have already three vaccines against COVID-19.’’

READ: Macron proposes 4-5% of COVID-19 vaccine doses for poorer nations

News continues after this ad


Russia has already approved 2 Covid-19 vaccines, including the Sputnik V shot, developed by Moscow’s Gamaleya Institute and has been approved in over 2 dozen countries across the globe.

The preemptive approvals which were first greeted with scepticism, had some scientists from the West raise concerns, but vaccinations with those first two shots began on a mass scale in Russia only after trials were concluded and showed success.

News continues after this ad


Sputnik V was approved in August and late-stage trials began in September. Mass vaccination was launched in December after preliminary trial results showed the vaccine to be 91.4% effective.

READ: Covid-19: Prime Minister of Eswatini dies of the virus

The Russian Health Minister, Mikhail Murashko had revealed that over 2 million Russians have been vaccinated with at least the first dose of Sputnik V, since then.

The rollout of a second vaccine, developed by the Vector Institute in Novosibirsk, is beginning.

The CoviVac vaccine which was produced by state-run Chumak Centre based in Moscow has employed a different method from Sputnik and EpiVacCorona, using inactive virus.

Unlike the Sputnik V vaccine, which uses a modified harmless cold virus that tricks the body into producing antigens to help the immune system prepare for a coronavirus infection, the CoviVac vaccine is a whole-virion vaccine.

READ: COVID-19: WHO advises vaccine firms and wealthy nations to stop bilateral deals

The Chumakov Centre’s director, Aidar Ishmukhametov, said on Saturday, “The vaccine we have developed… reflects the whole history of Russian, as well as global, vaccine science.’’

He said that the Chumakov Centre is expecting to produce around half a million doses per month on its platforms, Ishmukhametov said on Saturday.

Deputy Prime Minister Golikova also announced on Saturday that Russia will produce 88 million vaccine doses in the first half of this year, including 83 million Sputnik V doses.

What you should know

  • It can be recalled that in a televised government meeting, the Russian President, Vladimir Putin, had announced the registration of its first Covid-19 vaccine in what was then seen as a step ahead of other vaccine development.
  • The vaccine which was developed by Russia’s Gamaleya Institute in collaboration with the Russian Investment Fund was said to give effective protection against the deadly disease.
  • Russian President Vladimir Putin announced in October that the country had registered its second vaccine, EpiVacCorona, which health officials had said would enter mass production this month.

Related

Tags: Covid-19Sputnik V

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

inq
avatrade
Stanbic bank
Mega Millions
UBN
Hot forex
Access Bank
Bankers Committee
First bank






    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • NGX closes negative with the market cap down by N20 billion 
    • FG asks students to sue ASUU over strike, insists lecturers won’t be paid during the period
    • Hackers exploiting stolen cookies to attack corporate organisations – Report

    Follow us on social media:

    Recent News

    Weekly Stock Update: Nigerian local bourse’s ASI depreciates by 0.22% w-o-w

    NGX closes negative with the market cap down by N20 billion 

    August 18, 2022
    FG to review January 18 resumption date for schools across the country

    FG asks students to sue ASUU over strike, insists lecturers won’t be paid during the period

    August 18, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com